Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10052955HBVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS30001880HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS30005828HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS30005829HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS30000100HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS30001022HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS30004409HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS30075388HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS30029989HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TVIS30029990HIVENSG00000014138.10protein_codingPOLA2NoNo23649Q14181
TCGA Plot Options
Drug Information
GenePOLA2
DrugBank IDDB00851
Drug NameDacarbazine
Target IDBE0000716
UniProt IDQ14181
Regulation Typeother/unknown
PubMed IDs17139284; 17016423; 3098406
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Lonn U, Lohn S: Prevention of dacarbazine damage of human neoplastic cell DNA by aphidicolin. Cancer Res. 1987 Jan 1;47(1):26-30.
GroupsApproved; Investigational
Direct Classification2-heteroaryl carboxamides
SMILESCN(C)N=NC1=C(N=CN1)C(N)=O
Pathways
PharmGKBPA449197
ChEMBLCHEMBL476